Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target Cells-Reference-Cited by-同舟云学术

Bifunctional Janus Particles as Multivalent Synthetic Nanoparticle Antibodies (SNAbs) for Selective Depletion of Target Cells

Published:2021-01-04 Issue:1 Volume:21 Page:875-886
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Liu Jiaying,Toy Randall,Vantucci Casey,Pradhan Pallab,Zhang Zijian,Kuo Katie M.,Kubelick Kelsey P.,Huo Da,Wen Jianguo¹^ORCID,Kim Jinhwan,Lyu Zhiheng^ORCID,Dhal Simran,Atalis Alexandra,Ghosh-Choudhary Shohini K.²,Devereaux Emily J.³⁴,Gumbart James C.^ORCID,Xia Younan^ORCID,Emelianov Stanislav Y.^ORCID,Willett Nick J.³⁴,Roy Krishnendu^ORCID

Affiliation:

1. Center for Nanoscale Materials, Argonne National Laboratory, Lemont, Illinois 60517, United States

2. School of Medicine, University of Pittsburgh, 3550 Terrace St., Pittsburgh, Pennsylvania 15213, United States

3. Orthopaedics Department, Emory University, Atlanta, Georgia 30322, United States

4. Research Service, Atlanta VA Medical Center, Decatur, Georgia 30033, United States

Funder

Georgia Institute of Technology

Giglio Breast Cancer Innovation Fund

Children and Athletes Regenerative Medicine Foundation

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.0c04833

Reference68 articles.

1. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

2. Antibody therapy of cancer

3. Therapeutic antibodies: successes, limitations and hopes for the future

4. Antibody Phage Display: Technique and Applications

5. Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of Anisotropic Drug Delivery Systems;Advanced Materials;2024-01-07

2. Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors;Frontiers in Immunology;2023-08-03

3. Controlled spatial characteristics of ligands on nanoparticles: Determinant of cellular functions;Journal of Controlled Release;2023-08

4. Myeloid-derived suppressor cells and pulmonary hypertension;Frontiers in Immunology;2023-06-07

5. Allosteric synthetic antibody (Allo-SyAb) for improved cancer immunotherapy;Chemical Engineering Journal;2023-05